• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Determinants of poor clinical outcome in patients with influenza pneumonia: a systematic review and meta-analysis

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2023 Apr 6;S1201-9712(23)00135-2.
doi: 10.1016/j.ijid.2023.04.003. Online ahead of print.
Determinants of poor clinical outcome in patients with influenza pneumonia: a systematic review and meta-analysis


Javier Arranz-Herrero[SUP] 1 [/SUP], Jesús Presa[SUP] 2 [/SUP], Sergio Rius-Rocabert[SUP] 3 [/SUP], Alberto Utrero-Rico[SUP] 4 [/SUP], José Ángel Arranz-Arija[SUP] 5 [/SUP], Antonio Lalueza[SUP] 6 [/SUP], María Marta Escribese[SUP] 2 [/SUP], Jordi Ochando[SUP] 7 [/SUP], Vicente Soriano[SUP] 8 [/SUP], Estanislao Nistal-Villan[SUP] 9 [/SUP]



Affiliations
Free article

Abstract

Background: The clinical burden of influenza is increasing globally. Aging, immunosuppression, and underlying respiratory illness are determinants of poor clinical outcomes, including greater mortality. Bacterial infections seem to be the main reason. Updated information on the role of bacterial infection as the cause of complications would be of value in improving the prognosis of influenza patients.
Methods: A systematic review and meta-analysis were performed by using the Pubmed repository using keywords like: Influenza, H1N1, Streptococcus pneumoniae, bacterial coinfection, secondary coinfection, bacterial complications in pneumonia, and seasonal influenza. Only articles written in English were only included on publications from 2010 to 2020. Analyses were conducted following PRISMA guidelines. The results were independently validated using a TrinetX database cohort of roughly 4 million patients.
Results: We included 136 studies that contained data from 48,259 influenza-hospitalized patients of any age. Bacterial infections were diagnosed in 5,391 (11.2%). Streptococcus pneumoniae (30.7%) and Staphylococcus aureus (30.4%) were the most frequent microorganisms, followed by Haemophilus influenzae (7.1%) and Pseudomonas aeruginosa (5.9%). The random effects model of the meta-analysis indicated that bacterial infections posed a 3.4-fold increased risk of death compared to influenza infection alone. Unexpectedly, asthma was protective (odds ratio 0.8).
Conclusion: Bacterial infections diagnosed in 11.2% of influenza patients increase 3.4-fold the mortality risk. S. pneumoniae, S. aureus, H. influenzae and P. aeruginosa account for nearly 75% of cases. Earlier diagnosis and use of antibiotics should improve outcomes in this population.

Keywords: Influenza; Staphylococcus aureus; Streptococcus pneumoniae; antibiotic use; bacterial infection; outcome; prognosis.
 
Back
Top Bottom